REGN AS OF 12/31/2009

Company

REGENERON PHARMACEUTICALS, INC.

Filed

February 11, 2010

Accession Number

0000080255-10-000093

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →